On a per-share basis, the
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.16 USD | -0.83% | +9.20% | +91.74% |
06-03 | Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program | MT |
06-03 | Neurogene Inc. Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for Start Pilot Program | CI |
On a per-share basis, the
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source
1st Jan change | Capi. | |
---|---|---|
+91.74% | 482M | |
+55.55% | 59.28B | |
+43.40% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |